How the fund has supported Creo Medical 


Creo Medical, based in Chepstow, designs, develops and manufactures a unique electrosurgery platform and range of instruments enabling advancements in therapeutic endoscopy and minimally invasive surgery, driving improved outcomes for patients. The current product range provides a suite of therapeutic gastroenterology instruments for use via flexible endoscopy. The company’s CROMA platform will enable evolution into other therapeutic areas such as laparoscopic surgery and interventional cancer treatment.

The Angel CoFund originally invested into Creo Medical in October 2014 as part of a £3.5m funding round, alongside our co-investment partner the Arete Syndicate and other investors including Finance Wales. The initial funding round was used to further develop the technology whilst also advancing the regulatory approval process for the European market and establishing a regulatory pathway into the US market.

In September 2015 the Angel CoFund made a further investment into Creo Medical as part of a £5.5m round alongside existing investors and new investor, Pentax Medical (HOYA Group). This latest investment leaves the company well positioned to complete its US regulatory approval, build on its growing intellectual property portfolio and develop commercial traction in key global markets.

The CoFund is represented on Creo Medical’s Board by its lead angel who is a highly experienced investor into medical technologies.